期刊文献+

苯磺酸左旋氨氯地平对高血压病左心室舒张功能和左心室肥厚的影响 被引量:5

Effects of Levamlodipine Besylate on Left Ventricle Diastolic Function and Left Ventricular Hypertrophy in Patients with Primary Hypertension
原文传递
导出
摘要 目的:探讨原发性高血压患者经苯磺酸左旋氨氯地平治疗后其舒张功能和左室肥厚的变化。方法:选择100例经超声心动图证实具有左心室舒张功能障碍和左心室肥厚的高血压病患者,采用双盲法试验,随机均分为试验组与对照组。试验组给予苯磺酸左旋氨氯地平,对照组给予复方利血平氨苯蝶啶片,2组治疗3个月和6个月后分别复查各项心功能指标并进行两两比较。结果:2组治疗后患者左心室舒张功能、室间隔厚度、左心室后壁厚度、左心室重量指数均较治疗前有所改善,试验组下降更多,2组比较差异有统计学意义(P<0.05);试验组治疗6个月与治疗3个月时比较,差异有统计学意义(P<0.05),而对照组虽有下降,但差异无统计学意义(P>0.05)。结论:苯磺酸左旋氨氯地平能改善高血压患者左心室舒张功能和左心室的厚度。 OBJECTIVE:To investigate the effects of levamlodipine besylate on left ventricle diastolic function and left ventricular hypertrophy in patients with primary hypertension.METHODS:100 primary hypertension patients with left ventricle diastolic function and left ventricular hypertrophy checked by echocardiogram were randomized into treatment group and control group.Treatment group were given levamlodipine besylate and control group were given compound hypotensive tablets after 3 months and 6 months of treatment.Above indicators were rechecked and compared in pairwise comparison.RESULTS:Compared with before treatment,both left ventricle diastolic function and ventricular hypertrophy index of primary hypertension patients of 2 groups were improved significantly after treatment(P0.05).But treatment group were better than control group,there was statistical significance(P0.05).Compared with 3 months of treatment,the above index of treatment group were further improved after 6 months of treatment,there was statistical significance(P0.05).But control group had no statistical significance(P0.05).CONCLUSION:Levamlodipine besylate can improve left ventricle diastolic function and left ventricular thickness in primary hypertension patients
作者 罗先虎
出处 《中国药房》 CAS CSCD 2012年第44期4181-4182,共2页 China Pharmacy
关键词 苯磺酸左旋氨氯地平 左心室舒张功能 左心室肥厚 Levamlodipine besylate Left ventricle diastolic function Left ventricular hypertrophy
  • 相关文献

参考文献4

二级参考文献12

  • 1刘东,张晓雪,马丽雅,李雨林.高血压病左心室肥厚患者血浆脑钠素水平[J].高血压杂志,2004,12(5):396-399. 被引量:12
  • 2Packer M, Coats Ajs, Fowler MB, et al. Efect of Carvedilot On survival in severe chronic heart failure[J]. N Ensl J Med,2001,344(22) : 1651-1658.
  • 3Why H J, Richardson PJ. Elect ofcarvedilol on left ventricular function and mass in hypertension[J]. J Cardlovasc Phannaeol, 1992,19 ( Suppl 1 ):50-54.
  • 4KOHNO M, HRIO T, YOKOKAMA K, et al. Brain natriuretie peptide as a marker for Hypertensive left ventrieular hypertrophy: changes during 12 year antihypertensive therapy with angiotensin converting enzyme inhibitor[J]. Am J Med, 1995, 98(3) :257 -265.
  • 5DEVEREUX R B, ALONSO D R, LUTAS E M, et al. Echoeardlographic assessment of left ventricular hypertrophy: Comparison to necropsy finding [J]. Am J Cardiol, 1986, 57 : 450 - 453
  • 6MOTTRAM P M, LEANO R, MARWICK T H. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejec- tion fraction and correlation with new echocardiographic indexes of systolic and diastolic function[J]. Am J Cardiol, 2003, 92:1434 - 1438.
  • 7TALWAR S, SIEBENHOFER A, WILLIAMS B, et al. Influence of hypertension, left ventrivular hypertrophy, left ventrivular systolic dysfunction on plasma N terminal proBNP[J]. Heart, 2000, 83:278-282.
  • 8VERDECCHIA P, PORCELLATI C, REBOLDI G, et al. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension [J]. Circulation, 2001, 104:2039-2044.
  • 9吕艳青,周际安,曾繁典.卡维地洛的药理及临床研究进展[J].中国新药与临床杂志,1999,18(4):236-238. 被引量:34
  • 10夏朝红,杨玉雯,王新,汪祥海.氨氯地平治疗前后高血压病病人的降钙素基因相关肽及内皮素的变化[J].新医学,2000,31(8):467-467. 被引量:7

共引文献77

同被引文献49

  • 1冯培芳,徐大春,刘艳,冯久贤.卡维地洛改善SHR左室舒张功能及可能机制[J].浙江中医学院学报,2005,29(1):38-40. 被引量:1
  • 2肖琳玲,邓万俊.组织多普勒成像测定Tei指数评价高血压患者左室功能[J].中华高血压杂志,2006,14(12):1011-1012. 被引量:10
  • 3谢良地,欧阳秋芳,王华军.地尔硫对自发性高血压大鼠左心室舒张功能的影响及其可能机制[J].国际心血管病杂志,2007,34(4):284-288. 被引量:7
  • 4WHO-ISH,Hypertension Guidelines Committee. 1990 world health organization-international society of hypertension guidelines for the management of hypertension[J].Journal of Hypertension,2011,(09):151-183.
  • 5Khoo CW, Krishnamoorthy S, Lim HS, et al. Assessment of left atrial volume: a focus on echocardiographic methods and clinicalimplications[J]. Clin Res Cardiol,2011,100(2) :97-105.
  • 6Tuncer M, Guntekin U, Gunes Y, et al. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension[J]. Advances Therapy, 2008, 25(6) : 619-626.
  • 7Demiralp E, Karde~o~lu E, Celik T, et al. Short-term effect of nebivolol on the left ventrieular diastolic function [J]. Anadolu Kardiyol Derg,2004,4(4) :323-336.
  • 8Shantsila A, Dwivedi G, Shantsila E, et al. A comprehensive as- sessment of cardiac structure and function in patients with treated malignant phase hypertension~ the West Birmingham malignant hypertension pro.iect]-JJ. Int J Cardiol, 2013,167 ( 1 ) : 67-72.
  • 9Ivanovic BA, Tadic MV, Cello VP. To dip or not to dip? The u- nique relationship between different blood pressure patterns and cardiac function and structure[J]. J Hum Hypertens, 2013, 27 (1) ~62-70.
  • 10Mattioli AV, Zennaro M, Bonatti S, et al. Regression of left ventricular hypertrophy and improvement of diastolic function in hypertensive patients treated with telmisartan[J]. Int J Cardiol, 2004,97(3) :383-388.

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部